Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XG7K
|
|||
| Drug Name |
PMID27215781-Compound-29
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H14F6N2O4S
|
|||
| Canonical SMILES |
C1CC2CC1C3=C2C(=NC=C3NC4=CC(=CC=C4)OC(F)(F)F)OS(=O)(=O)C(F)(F)F
|
|||
| InChI |
1S/C18H14F6N2O4S/c19-17(20,21)29-12-3-1-2-11(7-12)26-13-8-25-16(30-31(27,28)18(22,23)24)15-10-5-4-9(6-10)14(13)15/h1-3,7-10,26H,4-6H2
|
|||
| InChIKey |
DQBACBSLAAPBLG-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | Agonist | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.